Pressure of Truth
Exposing the spin on all sides of the news.
Outlet profile

Drug Topics

U.S. trade press (pharmacy industry), mostly non-ideological

Owned byMJH Life Sciences, a privately held U.S. medical media company. MJH bought Drug Topics in 2019 as part of a package of brands from UBM Life Sciences Group.
FundingMainly advertising and sponsored content from pharmaceutical, pharmacy and healthcare companies. Other revenue likely includes MJH's events, continuing-education programs and marketing services. The sources I found do not give a breakdown.
On the administrationmostly neutral

Background

Drug Topics says it has served retail, community and health-system pharmacists since 1857. In 2019 MJH Life Sciences acquired it from UBM Life Sciences Group, along with brands such as Pharmaceutical Executive, Medical Economics, Dermatology Times and dvm360. MJH is a privately held company that calls itself the largest independent, full-service medical media company in North America. It has since expanded with launches such as Medical World News and the acquisition of BPD Healthcare. In 2021 Drug Topics added a companion resource for independent pharmacies, Total Pharmacy. As a trade outlet, its content focuses on drug news, reimbursement, pharmacy benefit manager practices, workforce issues and regulation. It carries industry advertising and sponsored material, so readers should expect a perspective sympathetic to pharmacy and the wider healthcare industry. Its political coverage, such as a piece on how the 2026 midterms could reshape pharmacy policy, tends toward explainers about policy effects rather than advocacy. I did not find notable controversies or any ideological editorial positions in the sources reviewed.

Sources

  1. Drug Topics
  2. Drug Topics Invests in Brand to Deliver Additional Value to Pharmacists
  3. Drug Topics Introduces Complementary Independent Pharmacy Resource Total Pharmacy (Business Wire)
  4. MJH Life Sciences Acquires BPD Healthcare
  5. FAQ: How the 2026 Midterms Could Reshape Pharmacy Policy

Profile compiled 2026-10-08; refreshed when ownership, funding, or the administration changes.

← Back to track record